Y
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
Price:
2.07
MYR
-0.48%
Market Closed
Market Cap:
293.6m
MYR
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Y
|
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
|
MY |
|
Yadong Group Holdings Ltd
HKEX:1795
|
HK |
|
Palla Pharma Ltd
ASX:PAL
|
AU |
|
Beijing Hotgen Biotech Co Ltd
SSE:688068
|
CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
A
|
Aiforia Technologies Oyj
OMXH:AIFORIA
|
FI |
|
E
|
Eik fasteignafelag hf
ICEX:EIK
|
IS |
|
Yasuda Logistics Corp
TSE:9324
|
JP |
|
Cannabix Technologies Inc
OTC:BLOZF
|
CA |
|
C
|
CleanCore Solutions Inc
AMEX:ZONE
|
US |
|
Waskita Karya (Persero) Tbk PT
IDX:WSKT
|
ID |
|
Audax Renovables SA
MAD:ADX
|
ES |
Multiples-Based Value
The Multiples-Based Value for YSP Southeast Asia Holding Bhd (YSPSAH) under the Base Case is hidden MYR. Compared with the current market price of 2.07 MYR, the stock appears hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
YSPSAH Multiples-Based Value
LOCKED
Multiples Across Competitors
YSPSAH Competitors Multiples
YSP Southeast Asia Holding Bhd Competitors
YSP Southeast Asia Holding Bhd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| MY |
Y
|
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
|
293.6m MYR | 0.8 | 11.7 | 4.7 | 4.7 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
837.7B USD | 13.3 | 42.1 | 28.4 | 30.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
588.6B USD | 6.2 | 22 | 15.2 | 18.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.4 | 11.5 | 13 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
227.8B GBP | 5.2 | 29.9 | 16.5 | 23.3 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
292.3B USD | 4.6 | 16.3 | 10.1 | 12.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.9B CHF | 5.3 | 21.5 | 13.3 | 17.1 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
157.9B USD | 2.6 | 20.5 | 7.8 | 10.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.4 | 10.1 | 7.5 | 8.8 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122.1B USD | 2.5 | 17.3 | 7.3 | 9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
